Cargando…

Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir

The sustained release of an antiretroviral agent to women mucosa has been proved as an excellent strategy to reduce the sexual transmission of HIV. Hybrid micro-mesoporous particles have been synthesized and functionalized with a silane coupling agent followed by loading the antiretroviral tenofovir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin-Illana, Araceli, Cazorla-Luna, Raul, Notario-Pérez, Fernando, Ruiz-Caro, Roberto, Bedoya, Luis Miguel, Veiga-Ochoa, Maria Dolores, Rubio, Juan, Tamayo, Aitana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476006/ https://www.ncbi.nlm.nih.gov/pubmed/32784712 http://dx.doi.org/10.3390/ma13163494

Ejemplares similares

Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
por: Cazorla-Luna, Raúl, et al.
Publicado: (2019)

Silicon Oxycarbide Porous Particles and Film Coating as Strategies for Tenofovir Controlled Release in Vaginal Tablets for HIV Prevention
por: Martín-Illana, Araceli, et al.
Publicado: (2022)

Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV
por: Notario-Pérez, Fernando, et al.
Publicado: (2017)

Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit(®) S100 for pH Responsive Release of Tenofovir
por: Cazorla-Luna, Raúl, et al.
Publicado: (2020)

Silane Modification of Mesoporous Materials for the Optimization of Antiviral Drug Adsorption and Release Capabilities in Vaginal Media
por: Whittle, Elena, et al.
Publicado: (2021)

Mucoadhesive Vaginal Discs based on Cyclodextrin and Surfactants for the Controlled Release of Antiretroviral Drugs to Prevent the Sexual Transmission of HIV
por: Notario-Pérez, Fernando, et al.
Publicado: (2020)

Tenofovir Hot-Melt Granulation using Gelucire(®) to Develop Sustained-Release Vaginal Systems for Weekly Protection against Sexual Transmission of HIV
por: Notario-Pérez, Fernando, et al.
Publicado: (2019)

Smart Freeze-Dried Bigels for the Prevention of the Sexual Transmission of HIV by Accelerating the Vaginal Release of Tenofovir during Intercourse
por: Martín-Illana, Araceli, et al.
Publicado: (2019)

Naturally Occurring Polyelectrolytes and Their Use for the Development of Complex-Based Mucoadhesive Drug Delivery Systems: An Overview
por: Cazorla-Luna, Raúl, et al.
Publicado: (2021)

Applications of Chitosan in Surgical and Post-Surgical Materials
por: Notario-Pérez, Fernando, et al.
Publicado: (2022)

Dapivirine Bioadhesive Vaginal Tablets Based on Natural Polymers for the Prevention of Sexual Transmission of HIV
por: Cazorla-Luna, Raúl, et al.
Publicado: (2019)

Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation
por: Sánchez-Sánchez, María-Pilar, et al.
Publicado: (2015)

Carrageenan-Based Acyclovir Mucoadhesive Vaginal Tablets for Prevention of Genital Herpes
por: Pacheco-Quito, Edisson-Mauricio, et al.
Publicado: (2020)

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes
por: Notario-Pérez, Fernando, et al.
Publicado: (2017)

Characterization and Dissolution Study of Chitosan Freeze-Dried Systems for Drug Controlled Release
por: Ruiz-Caro, Roberto, et al.
Publicado: (2009)

Preparation and Properties of Sustainable Brake Pads with Recycled End-of-Life Tire Rubber Particles
por: Tamayo, Aitana, et al.
Publicado: (2021)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis
por: Chaowanachan, Thanyanan, et al.
Publicado: (2013)

Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database
por: Kalemeera, Francis, et al.
Publicado: (2015)

The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis
por: Wang, Huilian, et al.
Publicado: (2016)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
por: Chua, Arlene C, et al.
Publicado: (2012)

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV
por: McLaughlin, Milena M, et al.
Publicado: (2018)

Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy
por: Horizon, Arash A, et al.
Publicado: (2011)

Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen
por: Krishna, M. Murali, et al.
Publicado: (2014)

Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir
por: Yilma, Daniel, et al.
Publicado: (2020)

Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate
por: Simpson, Solange M, et al.
Publicado: (2020)

Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair
por: Nematadzira, Teacler G., et al.
Publicado: (2022)

Milk Calcium and Phosphorus in Ugandan Women with HIV on Tenofovir-Based Antiretroviral Therapy
por: Nabwire, Florence, et al.
Publicado: (2023)

Insights into the Microstructural Evolution Occurring during Pyrolysis of Metal-Modified Ceramers Studied through Selective SiO(2) Removal
por: Tamayo, Aitana, et al.
Publicado: (2021)

Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence
por: Gandhi, Monica, et al.
Publicado: (2018)

In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers
por: An, Weiteng, et al.
Publicado: (2021)

Protein sustained release from isobutyramide-grafted stellate mesoporous silica nanoparticles
por: Bizeau, Joëlle, et al.
Publicado: (2022)

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
por: Padilla, Authors: Sergio, et al.
Publicado: (2011)

Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
por: Dorjee, Kunchok, et al.
Publicado: (2021)

Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti
por: Pierre, Samuel, et al.
Publicado: (2021)

Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
por: Estrada, Vicente, et al.
Publicado: (2022)

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study
por: Keene, Claire M, et al.
Publicado: (2021)

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
por: Wassner, Chanie, et al.
Publicado: (2020)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Mesoporous calcium–silicon xerogels with mesopore size and pore volume influence hMSC behaviors by load and sustained release of rhBMP-2
por: Song, Wenhua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vcmrv5q5agifpc2k234rqrs1vq